Friday, July 10, 2026

Drug profile · INN

bevacizumab-nwgd

bevacizumab-nwgd (JOBEVNE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — bevacizumab-nwgd
US status
approved
Class
Route
INJECTION
Patents
0
Programs
0
Data quality
0.84

Quick answer

bevacizumab-nwgd (JOBEVNE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN bevacizumab-nwgd
Brand JOBEVNE
Route INJECTION
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is bevacizumab-nwgd?

bevacizumab-nwgd (JOBEVNE) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for bevacizumab-nwgd?

JOBEVNE is a marketed brand name for bevacizumab-nwgd. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of bevacizumab-nwgd?

bevacizumab-nwgd has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.